269 related articles for article (PubMed ID: 19078928)
21. Management of advanced-stage and recurrent endometrial cancer.
Ray M; Fleming G
Semin Oncol; 2009 Apr; 36(2):145-54. PubMed ID: 19332249
[TBL] [Abstract][Full Text] [Related]
22. Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway.
Lee PS; Secord AA
Cancer Treat Rev; 2014 May; 40(4):507-12. PubMed ID: 24332498
[TBL] [Abstract][Full Text] [Related]
23. Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.
Konecny GE; Finkler N; Garcia AA; Lorusso D; Lee PS; Rocconi RP; Fong PC; Squires M; Mishra K; Upalawanna A; Wang Y; Kristeleit R
Lancet Oncol; 2015 Jun; 16(6):686-94. PubMed ID: 25981814
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant treatment of advanced-stage endometrial cancer.
Lee NK
Clin Obstet Gynecol; 2011 Jun; 54(2):256-65. PubMed ID: 21508695
[TBL] [Abstract][Full Text] [Related]
25. Treatment options for advanced endometrial carcinoma.
Dizon DS
Gynecol Oncol; 2010 May; 117(2):373-81. PubMed ID: 20223510
[TBL] [Abstract][Full Text] [Related]
26. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
27. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
Karagol H; Saip P; Uygun K; Kucucuk S; Aydiner A; Topuz E
Med Oncol; 2006; 23(4):543-8. PubMed ID: 17303913
[TBL] [Abstract][Full Text] [Related]
29. New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
Rodriguez-Freixinos V; Karakasis K; Oza AM
Curr Oncol Rep; 2016 Apr; 18(4):23. PubMed ID: 26922329
[TBL] [Abstract][Full Text] [Related]
30. Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS).
Tzakas E; Liu S; Todd RW; Redman CW
J Obstet Gynaecol; 2009 Nov; 29(8):778-9. PubMed ID: 19821687
[No Abstract] [Full Text] [Related]
31. Resistance to chemotherapy and hormone therapy in endometrial cancer.
Chaudhry P; Asselin E
Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy in endometrial cancer.
Obel JC; Friberg G; Fleming GF
Clin Adv Hematol Oncol; 2006 Jun; 4(6):459-68. PubMed ID: 16981669
[TBL] [Abstract][Full Text] [Related]
33. Promising novel therapies for the treatment of endometrial cancer.
Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2010 Feb; 116(2):187-94. PubMed ID: 19903572
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.
Tsoref D; Welch S; Lau S; Biagi J; Tonkin K; Martin LA; Ellard S; Ghatage P; Elit L; Mackay HJ; Allo G; Tsao MS; Kamel-Reid S; Eisenhauer EA; Oza AM
Gynecol Oncol; 2014 Nov; 135(2):184-9. PubMed ID: 25173583
[TBL] [Abstract][Full Text] [Related]
35. Medical therapy of endometrial cancer: current status and promising novel treatments.
Hill EK; Dizon DS
Drugs; 2012 Mar; 72(5):705-13. PubMed ID: 22439671
[TBL] [Abstract][Full Text] [Related]
36. Endometrial cancer.
Morice P; Leary A; Creutzberg C; Abu-Rustum N; Darai E
Lancet; 2016 Mar; 387(10023):1094-1108. PubMed ID: 26354523
[TBL] [Abstract][Full Text] [Related]
37. Emerging drugs for endometrial cancer.
Amadio G; Masciullo V; Ferrandina MG; Scambia G
Expert Opin Emerg Drugs; 2014 Dec; 19(4):497-509. PubMed ID: 25330855
[TBL] [Abstract][Full Text] [Related]
38. [Advanced endometrial carcinoma: primary debulking surgery or neoadjuvant chemotherapy?].
Guyon F; Stoeckle E; Thomas L; Petit A; Sire M; Floquet A
Bull Cancer; 2012 Jan; 99(1):43-9. PubMed ID: 22198346
[TBL] [Abstract][Full Text] [Related]
39. Advances in the management of recurrent endometrial cancer.
Bradford LS; Rauh-Hain JA; Schorge J; Birrer MJ; Dizon DS
Am J Clin Oncol; 2015 Apr; 38(2):206-12. PubMed ID: 23764681
[TBL] [Abstract][Full Text] [Related]
40. Developments in the systemic treatment of endometrial cancer.
Mountzios G; Pectasides D; Bournakis E; Pectasides E; Bozas G; Dimopoulos MA; Papadimitriou CA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):278-92. PubMed ID: 20833559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
